GL1X · GenesisL1 explorer

Research workbench

Structure of human anaplastic lymphoma kinase domain in complex with ((2~{R})-2-[5-[6-amino-5-[(1~{R})-1-[5-fluoro-2-(triazol-2-yl) PHENYL]ETHOXY]-3-pyridyl]-4-methyl-thiazol-2-YL]PROPANE-1,2-diol)

Analyse Structure of human anaplastic lymphoma kinase domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7R7R
Type
protein
Length
291 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
AWJ
Pockets
1 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein29143% helix, 16% strandQ9UM73

Ligands and binding sites

  • AWJ · (2R)-2-[5-(6-amino-5-{(1R)-1-[2-(1,3-dihydro-2H-1,2,3-triazol-2-yl)-5-fluorophenyl]ethoxy}pyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]propane-1,2-diol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12990.590.7837AWJ

Compared structures

  • 7R7R · Structure of Human Anaplastic Lymphoma Kinase Domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.